Provided by Tiger Trade Technology Pte. Ltd.

EDGE MEDICAL-B

58.050
+2.0503.66%
Volume:2.32M
Turnover:136.73M
Market Cap:22.51B
PE:-92.88
High:61.950
Open:56.050
Low:54.500
Close:56.000
52wk High:61.950
52wk Low:48.000
Shares:387.72M
HK Float Shares:324.00M
Volume Ratio:0.32
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.625
ROE:--
ROA:--
PB:16.98
PE(LYR):-92.88
PS:72.04

Loading ...

Company Profile

Company Name:
EDGE MEDICAL-B
Exchange:
SEHK
Establishment Date:
2017
Employees:
- -
Office Location:
Room 1901, Building 2B,Smart Park Phase II,Baolong Street,Longgang District,Shenzhen,Guangdong Province,China
Zip Code:
- -
Fax:
- -
Introduction:
Established in 2017, we are an advanced surgical Robotics company in the medical device industry, dedicated to the design, development and manufacture of surgical Robotics. The Jingfeng multi-hole endoscopic surgical Robotics MP1000 is our recommended core product, while the Jingfeng single-hole endoscopic surgical Robotics SP1000 is our key product under development. According to Frost & Sullivan, we are the first company in China to complete critical clinical trials of multi-hole and single-hole endoscopic surgical Robotics. Both 1MP1000 and SP1000 are qualified for rapid review of innovative medical devices by the State Drug Administration through the green channel. We received approval from the National Drug Administration to register the MP1000 for urological surgery in December 2022. The Chinese surgical Robotics market is fiercely competitive. According to Frost & Sullivan's data, on the last practical date, we had five companies in China approved multi-hole endoscopic surgery Robotics, but none of the single-hole endoscopic surgical Robotics were approved. In addition to the MP1000 and SP1000, we have five other pipeline products under development. As of the last effective date, we have been granted more than 500 patents and patent applications worldwide. As of the same date, we Hold 48 patents and 54 patent applications relating only to the MP1000, 63 patents and 28 patent applications relating only to the SP1000, and 127 patents and 83 patent applications relating to both the MP1000 and SP1000.

Directors

Name
Position
WANG Jian Chen
Chairman of the Board,Executive Director
WU Meng Yuan
Executive Director,Member of the Remuneration and Assessment Committee
GAO Yuan Qian
Executive Director,Member of the Nomination Committee
YANG Fan
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
LAU Ying Kit
Independent Director,Member of the Audit Committee
ZHANG Guo Guang
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Chairman of the Audit Committee
SHENG Li
Director,Member of the Audit Committee
CHEN Gang
Director
QIU Xiang
Director
XIE Guo Qiang
Supervisor,Supervisory
ZHANG Xiang Ping
Supervisory
LIN Min Cai
Supervisory

Shareholders

Name
Position
WANG Jian Chen
CEO,General Manager
GAO Yuan Qian
Vice General Manager,CFO,CTO,Senior Technical Personnel
WU Meng Yuan
Board Secretary,Corporate Secretary
LI Jian Wei
Corporate Secretary
CHEN Zong Xi
Chief Business Officer
HAN Wen Bin
Other Senior Executives